Longitudinal analysis of complete blood count parameters in advanced‐stage lung cancer patients

BACKGROUND: Metastatic lung cancer is a debilitating disease, but with the advances in immunotherapy, therapeutic options have vastly increased. Numerous complete blood count parameters (CBC) have been described as easily accessible biomarkers that might predict response to immunotherapy. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojko, Livia, Megyesfalvi, Zsolt, Czibula, Eszter, Reiniger, Lilla, Teglasi, Vanda, Szegedi, Zsolt, Szallasi, Zoltan, Dome, Balazs, Moldvay, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605999/
https://www.ncbi.nlm.nih.gov/pubmed/32941706
http://dx.doi.org/10.1111/1759-7714.13642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605999/
https://www.ncbi.nlm.nih.gov/pubmed/32941706
http://dx.doi.org/10.1111/1759-7714.13642

Ejemplares similares